Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance.
- NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_assertion wasGeneratedBy ECO_0000203 NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance.
- NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_assertion wasDerivedFrom befree-20140225 NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance.
- NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_assertion SIO_000772 10942517 NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance.
- NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_assertion evidence source_evidence_literature NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance.
- NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_assertion description "[Treatment of human melanoma cells with a combination of recombinant fibroblast interferon (IFN-beta) and the protein kinase C (PKC) activator mezerein (MEZ) causes a rapid and irreversible suppression in growth and terminal cell differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance.